{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:25:18Z","timestamp":1782552318978,"version":"3.54.5"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T00:00:00Z","timestamp":1395273600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002746","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T20:38:29Z","timestamp":1395347909000},"page":"e2746","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Development of a Novel, Single-Cycle Replicable Rift Valley Fever Vaccine"],"prefix":"10.1371","volume":"8","author":[{"given":"Shin","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney I.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"D69","DOI":"10.1016\/j.vaccine.2009.07.046","article-title":"Rift valley fever vaccines","volume":"27 Suppl 4","author":"T Ikegami","year":"2009","journal-title":"Vaccine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1128\/JVI.02641-10","article-title":"Rift valley fever: recent insights into pathogenesis and prevention","volume":"85","author":"H Boshra","year":"2011","journal-title":"J Virol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2460\/javma.234.7.883","article-title":"Rift Valley fever virus","volume":"234","author":"BH Bird","year":"2009","journal-title":"J Am Vet Med Assoc"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4269\/ajtmh.1988.38.440","article-title":"Vector potential of selected North American mosquito species for Rift Valley fever virus","volume":"38","author":"TP Gargan","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-8579(02)00295-9","article-title":"Rift Valley fever: an uninvited zoonosis in the Arabian peninsula","volume":"21","author":"HH Balkhy","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"ref6","unstructured":"Peters CJ, Meegan JM (1989) Rift Valley fever virus. Boca Raton, FL: CRC Press."},{"key":"ref7","unstructured":"Peters CJ, LeDuc JW (1999) Bunyaviruses, Phleboviruses, and related viruses. In: Belshe RB, editor. Textbook of Human Virology. 2nd ed: Mosby Year Book. pp. 571\u2013614."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.coviro.2012.02.017","article-title":"Breaking the chain: Rift Valley fever virus control via livestock vaccination","volume":"2","author":"BH Bird","year":"2012","journal-title":"Curr Opin Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0923-2516(91)90069-F","article-title":"Antigenic analysis of Rift Valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains","volume":"142","author":"TG Besselaar","year":"1991","journal-title":"Res Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(80)91395-1","article-title":"Serological relation between Rift Valley fever virus and viruses of phlebotomus fever serogroup","volume":"1","author":"RE Shope","year":"1980","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4269\/ajtmh.1982.31.149","article-title":"Studies on the antigenic relationship among phleboviruses","volume":"31","author":"RB Tesh","year":"1982","journal-title":"Am J Trop Med Hyg"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"K Spik","year":"2006","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0042-6822(89)90365-6","article-title":"Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins","volume":"170","author":"CS Schmaljohn","year":"1989","journal-title":"Virology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"PR Pittman","year":"1999","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0166-3542(86)90024-0","article-title":"Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator","volume":"6","author":"CJ Peters","year":"1986","journal-title":"Antiviral Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01311021","article-title":"Experimental Rift Valley fever in rhesus macaques","volume":"99","author":"CJ Peters","year":"1988","journal-title":"Arch Virol"},{"key":"ref17","first-page":"197","article-title":"Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters","volume":"92","author":"BS Niklasson","year":"1984","journal-title":"Acta Pathol Microbiol Immunol Scand C"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2460\/ajvr.1980.41.10.1559","article-title":"Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep","volume":"41","author":"DG Harrington","year":"1980","journal-title":"Am J Vet Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01316748","article-title":"Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies","volume":"121","author":"TG Besselaar","year":"1991","journal-title":"Arch Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0042-6822(87)90174-7","article-title":"Immunoelectron microscopy of Rift Valley fever viral morphogenesis in primary rat hepatocytes","volume":"161","author":"GW Anderson","year":"1987","journal-title":"Virology"},{"issue":"Pt 10","key":"ref21","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66","author":"H Caplen","year":"1985","journal-title":"J Gen Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0034-5288(92)90029-2","article-title":"Comparison of the pathogenicity for pregnant sheep of Rift Valley fever virus and a live attenuated vaccine","volume":"52","author":"A Baskerville","year":"1992","journal-title":"Res Vet Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2460\/ajvr.1991.52.01.50","article-title":"Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever","volume":"52","author":"KA Hubbard","year":"1991","journal-title":"Am J Vet Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep","volume":"9","author":"JC Morrill","year":"1991","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"JC Morrill","year":"1987","journal-title":"Am J Vet Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"JC Morrill","year":"1997","journal-title":"Am J Vet Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","article-title":"Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids","volume":"58","author":"JC Morrill","year":"1997","journal-title":"Am J Vet Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/S0264-410X(03)00131-2","article-title":"Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys","volume":"21","author":"JC Morrill","year":"2003","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"14926","DOI":"10.1073\/pnas.1112149108","article-title":"Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice","volume":"108","author":"JF Papin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","article-title":"Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter","volume":"73","author":"UJ Buchholz","year":"1999","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene","volume":"80","author":"T Ikegami","year":"2006","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1073\/pnas.1013155108","article-title":"Mechanism of tripartite RNA genome packaging in Rift Valley fever virus","volume":"108","author":"K Terasaki","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"13567","DOI":"10.1073\/pnas.1834876100","article-title":"Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation","volume":"100","author":"T Akagi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/JVI.58.2.263-270.1986","article-title":"Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus","volume":"58","author":"K Keegan","year":"1986","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.virol.2006.07.035","article-title":"Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors","volume":"356","author":"CM Filone","year":"2006","journal-title":"Virology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1128\/JVI.06009-11","article-title":"Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion","volume":"86","author":"S Murakami","year":"2012","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1128\/JVI.69.7.3972-3979.1995","article-title":"The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules","volume":"69","author":"N Lopez","year":"1995","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1128\/JVI.79.9.5606-5615.2005","article-title":"Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system","volume":"79","author":"T Ikegami","year":"2005","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e9986","DOI":"10.1371\/journal.pone.0009986","article-title":"Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA","volume":"5","author":"JC Morrill","year":"2010","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.1128\/JVI.00767-07","article-title":"The cytoplasmic tails of Uukuniemi Virus (Bunyaviridae) G(N) and G(C) glycoproteins are important for intracellular targeting and the budding of virus-like particles","volume":"81","author":"AK Overby","year":"2007","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1073\/pnas.1217780110","article-title":"Crystal structure of glycoprotein C from Rift Valley fever virus","volume":"110","author":"M Dessau","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-4682-1-10","article-title":"Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes)","volume":"1","author":"CE Garry","year":"2004","journal-title":"Theor Biol Med Model"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/JVI.75.9.4268-4275.2001","article-title":"Mutational evidence for an internal fusion peptide in flavivirus envelope protein E","volume":"75","author":"SL Allison","year":"2001","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/JVI.07104-11","article-title":"Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge","volume":"86","author":"KA Dodd","year":"2012","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.1128\/JVI.00841-11","article-title":"Creation of a nonspreading Rift Valley fever virus","volume":"85","author":"J Kortekaas","year":"2011","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1128\/JVI.79.18.12106-12111.2005","article-title":"Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment","volume":"79","author":"T Ikegami","year":"2005","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"13271","DOI":"10.1128\/JVI.01647-07","article-title":"Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1\/S1P is critical for virus infectivity","volume":"81","author":"E Bergeron","year":"2007","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e2430","DOI":"10.1371\/journal.pntd.0002430","article-title":"A Fusion-Inhibiting Peptide against Rift Valley Fever Virus Inhibits Multiple, Diverse Viruses","volume":"7","author":"JW Koehler","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref49","first-page":"808","article-title":"A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up","volume":"116","author":"JD Kark","year":"1982","journal-title":"Am J Epidemiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0264-410X(85)90060-X","article-title":"A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection","volume":"3","author":"JD Kark","year":"1985","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1128\/JVI.00778-12","article-title":"The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine","volume":"86","author":"O Lihoradova","year":"2012","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2007.01.046","article-title":"Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease","volume":"362","author":"BH Bird","year":"2007","journal-title":"Virology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals","volume":"82","author":"BH Bird","year":"2008","journal-title":"J Virol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/JVI.74.3.1538-1543.2000","article-title":"The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice","volume":"74","author":"P Vialat","year":"2000","journal-title":"J Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1128\/JVI.01238-07","article-title":"NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis","volume":"81","author":"S Won","year":"2007","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1128\/JVI.06046-11","article-title":"Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep","volume":"85","author":"BH Bird","year":"2011","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2009.11.001","article-title":"A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge","volume":"397","author":"RB Mandell","year":"2010","journal-title":"Virology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus","volume":"385","author":"J N\u00e4slund","year":"2009","journal-title":"Virology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/vbz.2009.0248","article-title":"Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus","volume":"10","author":"A Pichlmair","year":"2010","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.virol.2007.04.014","article-title":"Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins","volume":"366","author":"R Gorchakov","year":"2007","journal-title":"Virology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1371\/journal.pntd.0000725","article-title":"Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus","volume":"4","author":"N Bhardwaj","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.vaccine.2009.12.062","article-title":"Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge","volume":"28","author":"SM de Boer","year":"2010","journal-title":"Vaccine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"J Kortekaas","year":"2012","journal-title":"Vaccine"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.1132505","article-title":"5\u2032-Triphosphate RNA is the ligand for RIG-I","volume":"314","author":"V Hornung","year":"2006","journal-title":"Science"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.1132998","article-title":"RIG-I-mediated antiviral responses to single-stranded RNA bearing 5\u2032-phosphates","volume":"314","author":"A Pichlmair","year":"2006","journal-title":"Science"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.immuni.2009.05.008","article-title":"Recognition of 5\u2032 triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus","volume":"31","author":"M Schlee","year":"2009","journal-title":"Immunity"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"12067","DOI":"10.1073\/pnas.0900971106","article-title":"5\u2032-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I","volume":"106","author":"A Schmidt","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1128\/JVI.01997-12","article-title":"RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge","volume":"87","author":"ME Ermler","year":"2013","journal-title":"J Virol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.chom.2013.01.012","article-title":"Incoming RNA virus nucleocapsids containing a 5\u2032-triphosphorylated genome activate RIG-I and antiviral signaling","volume":"13","author":"M Weber","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1183021","article-title":"Regulation of adaptive immunity by the innate immune system","volume":"327","author":"A Iwasaki","year":"2010","journal-title":"Science"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"e1000138","DOI":"10.1371\/journal.ppat.1000138","article-title":"Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling","volume":"4","author":"F Geeraedts","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"25ra24","DOI":"10.1126\/scitranslmed.3000759","article-title":"Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes","volume":"2","author":"S Koyama","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1128\/JVI.01973-12","article-title":"Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein","volume":"86","author":"SM de Boer","year":"2012","journal-title":"J Virol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"R Muller","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref75","first-page":"95","article-title":"Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep","volume":"69","author":"P Hunter","year":"2002","journal-title":"Onderstepoort J Vet Res"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1016\/j.vaccine.2013.08.003","article-title":"Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves","volume":"31","author":"JC Morrill","year":"2013","journal-title":"Vaccine"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T03:35:31Z","timestamp":1746156931000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002746"}},"subtitle":[],"editor":[{"given":"Brian","family":"Bird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,20]]},"references-count":76,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002746","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,20]]}}}